China reveals 2009 results of regulatory measures
This article was originally published in SRA
Executive Summary
A summary of drug review activities by China’s State Food and Drug Administration in 2009 has signalled that measures by the agency to tighten its control of drugs and enhance and facilitate the regulatory review of products are producing positive results. Neena Brizmohun reports from the 46th Annual Meeting of the Drug Information Association in Washington, DC, from 13-17 June.